Categories AlphaGraphs, Earnings, Health Care
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the market’s prediction.
Adjusted earnings increased 29% to $2.11 per share from $1.64 per share a year earlier. Analysts were looking for a smaller bottom-line number.
Net income, on an unadjusted basis, came in at $360 million or $0.29 per share, compared to a loss of $1.17 billion or $0.92 per share in the prior-year period.
Read management/analysts’ comments on Gilead Sciences Q3 earnings
Revenues moved up 17% year-over-year to $6.58 billion in the September-quarter and exceeded the market’s prediction. The company’s stock closed Wednesday’s regular trading lower, hut gained during the after-hours session.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Alibaba Group (BABA) Q2 2025 Earnings: Key financials and quarterly highlights
Alibaba Group Holding Limited (NYSE: BABA) reported its second quarter 2025 earnings results today. Revenue was $33.7 billion, up 5% year-over-year. Net income attributable to ordinary shareholders grew 58% to
AMAT Earnings: Applied Materials Q4 revenue and profit increase YoY
Applied Materials, Inc. (NASDAQ: AMAT) announced financial results for the fourth quarter of 2024, reporting an increase in revenue and adjusted earnings. Adjusted earnings of the semiconductor technology company increased
What to expect when Target (TGT) reports its Q3 2024 earnings results
Shares of Target Corporation (NYSE: TGT) stayed green on Thursday. The stock has gained 9% over the past three months. The retailer is scheduled to report its earnings results for
